Thu, January 25, 2024

Luke Sergott Maintained (TWST) at Buy with Increased Target to $45 on, Jan 25th, 2024

Luke Sergott of Barclays, Maintained "Twist Bioscience Corporation" (TWST) at Buy with Increased Target from $30 to $45 on, Jan 25th, 2024.

Luke has made no other calls on TWST in the last 4 months.



There are 2 other peers that have a rating on TWST. Out of the 2 peers that are also analyzing TWST, 0 agree with Luke's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Luke


  • Matthew Sykes of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $45 on, Thursday, January 18th, 2024
  • Gaurav Goparaju of "Berenberg" Initiated at Strong Buy and Held Target at $27 on, Wednesday, September 27th, 2023